$1.44 Billion is the total value of Eversept Partners, LP's 102 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 74.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $82,040,457 | +3.2% | 444,471 | +0.3% | 5.70% | +7.5% |
| ASND | Buy | ASCENDIS PHARMA A/Ssponsored adr | $70,960,906 | +123.1% | 445,203 | +84.1% | 4.93% | +132.4% |
| CYH | Buy | COMMUNITY HEALTH SYS INC NEW | $70,061,507 | +18.7% | 5,988,163 | +56.7% | 4.86% | +23.7% |
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $69,521,752 | +11.4% | 634,670 | -4.8% | 4.83% | +16.0% |
| XLRN | Buy | ACCELERON PHARMA INC | $60,147,917 | +43.1% | 349,494 | +4.3% | 4.18% | +49.0% |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $59,185,449 | -18.9% | 11,604,990 | -30.4% | 4.11% | -15.6% |
| GSK | Buy | GLAXOSMITHKLINE PLCcall | $57,456,377 | +2.8% | 1,503,700 | +7.1% | 3.99% | +7.1% |
| AZN | Sell | ASTRAZENECA PLCsponsored adr | $53,501,928 | -9.4% | 890,808 | -9.6% | 3.71% | -5.6% |
| AVTR | Buy | AVANTOR INC | $52,843,373 | +52.7% | 1,292,014 | +32.6% | 3.67% | +59.0% |
| ARKG | Sell | ARK ETF TRgenomic rev etf | $51,519,515 | -28.0% | 689,501 | -10.9% | 3.58% | -25.0% |
| DHR | Sell | DANAHER CORPORATION | $45,068,183 | -18.0% | 147,938 | -27.7% | 3.13% | -14.6% |
| SPY | Sell | SPDR S&P 500 ETF TRput | $42,914,000 | -59.9% | 100,000 | -60.0% | 2.98% | -58.2% |
| AMRX | Buy | AMNEAL PHARMACEUTICALS INC | $36,578,114 | +27.0% | 6,849,834 | +21.8% | 2.54% | +32.3% |
| LH | New | LABORATORY CORP AMER HLDGS | $36,111,848 | – | 128,311 | +100.0% | 2.51% | – |
| TEVA | Sell | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $34,623,791 | -8.1% | 3,554,804 | -6.6% | 2.40% | -4.2% |
| NVST | Buy | ENVISTA HOLDINGS CORPORATION | $33,902,935 | +19.6% | 810,881 | +23.6% | 2.35% | +24.6% |
| MCK | Buy | MCKESSON CORP | $32,288,796 | +124.6% | 161,708 | +115.6% | 2.24% | +133.9% |
| VRTX | VERTEX PHARMACEUTICALS INCcall | $31,434,887 | -10.0% | 173,300 | 0.0% | 2.18% | -6.3% | |
| BMY | Sell | BRISTOL-MYERS SQUIBB CO | $27,791,346 | -13.0% | 464,801 | -2.8% | 1.93% | -9.4% |
| CTLT | New | CATALENT INC | $24,524,668 | – | 184,299 | +100.0% | 1.70% | – |
| ICLR | New | ICON PLC | $18,842,120 | – | 71,911 | +100.0% | 1.31% | – |
| MASI | New | MASIMO CORP | $18,137,570 | – | 67,000 | +100.0% | 1.26% | – |
| OCDX | Sell | ORTHO CLINICAL DIAGNOSTICS H | $16,908,941 | -43.4% | 914,986 | -34.4% | 1.17% | -41.0% |
| RCM | Sell | R1 RCM INC | $16,832,808 | -1.7% | 764,780 | -0.7% | 1.17% | +2.5% |
| MRVI | Buy | MARAVAI LIFESCIENCES HLDGS I | $16,088,915 | +414.1% | 327,810 | +337.1% | 1.12% | +434.4% |
| AZN | New | ASTRAZENECA PLCcall | $15,633,618 | – | 260,300 | +100.0% | 1.08% | – |
| FATE | Sell | FATE THERAPEUTICS INC | $15,463,247 | -48.6% | 260,895 | -24.7% | 1.07% | -46.4% |
| GSK | Buy | GLAXOSMITHKLINE PLCsponsored adr | $15,410,002 | +234.0% | 401,654 | +256.5% | 1.07% | +248.5% |
| IONS | Buy | IONIS PHARMACEUTICALS INC | $15,109,804 | -14.3% | 450,501 | +1.9% | 1.05% | -10.7% |
| CYH | New | COMMUNITY HEALTH SYS INC NEWcall | $12,603,240 | – | 1,077,200 | +100.0% | 0.88% | – |
| GH | Buy | GUARDANT HEALTH INC | $12,546,129 | +5484.5% | 100,361 | +5447.9% | 0.87% | +5706.7% |
| NTRA | Buy | NATERA INC | $12,502,342 | +1082.3% | 112,189 | +1104.5% | 0.87% | +1140.0% |
| SNY | New | SANOFIsponsored adr | $12,492,561 | – | 259,128 | +100.0% | 0.87% | – |
| ANTM | Buy | ANTHEM INC | $11,790,918 | +204.8% | 31,628 | +212.2% | 0.82% | +217.4% |
| ZGNX | Buy | ZOGENIX INC | $11,766,037 | +37.3% | 774,591 | +56.2% | 0.82% | +43.1% |
| TARO | Buy | TARO PHARMACEUTICAL INDS LTD | $11,413,059 | -9.0% | 179,366 | +2.9% | 0.79% | -5.3% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $11,183,783 | +29.0% | 59,233 | +15.8% | 0.78% | +34.3% |
| EXEL | Buy | EXELIXIS INC | $10,914,730 | +232.8% | 516,307 | +186.8% | 0.76% | +246.1% |
| MGLN | MAGELLAN HEALTH INC | $9,899,385 | +0.4% | 104,700 | 0.0% | 0.69% | +4.6% | |
| HUM | Buy | HUMANA INC | $9,390,507 | +13.5% | 24,083 | +29.1% | 0.65% | +18.3% |
| TEVA | Buy | TEVA PHARMACEUTICAL INDS LTDcall | $9,373,776 | +390.8% | 962,400 | +398.9% | 0.65% | +412.6% |
| HCA | Buy | HCA HEALTHCARE INC | $9,312,196 | +441.8% | 38,366 | +361.5% | 0.65% | +461.7% |
| CNC | Buy | CENTENE CORP DEL | $8,792,377 | +77.3% | 141,107 | +107.5% | 0.61% | +84.3% |
| ITCI | Buy | INTRA-CELLULAR THERAPIES INC | $8,602,136 | +79.4% | 230,744 | +96.4% | 0.60% | +86.6% |
| PKI | New | PERKINELMER INC | $8,158,666 | – | 47,081 | +100.0% | 0.57% | – |
| NSTG | New | NANOSTRING TECHNOLOGIES INC | $8,097,751 | – | 168,668 | +100.0% | 0.56% | – |
| HZNP | HORIZON THERAPEUTICS PUB Lcall | $7,667,800 | +17.0% | 70,000 | 0.0% | 0.53% | +21.7% | |
| HQY | Sell | HEALTHEQUITY INC | $7,407,119 | -53.4% | 114,378 | -42.1% | 0.51% | -51.5% |
| QGEN | Sell | QIAGEN NV | $7,395,873 | -76.5% | 143,109 | -78.0% | 0.51% | -75.6% |
| IRTC | New | IRHYTHM TECHNOLOGIES INC | $6,667,290 | – | 113,854 | +100.0% | 0.46% | – |
| GOCO | Buy | GOHEALTH INC | $6,346,467 | +721.7% | 1,261,723 | +1731.3% | 0.44% | +764.7% |
| HRC | New | HILL-ROM HLDGS INC | $4,500,000 | – | 30,000 | +100.0% | 0.31% | – |
| HRC | New | HILL-ROM HLDGS INCcall | $4,410,000 | – | 29,400 | +100.0% | 0.31% | – |
| LXRX | Buy | LEXICON PHARMACEUTICALS INC | $4,197,658 | +298.9% | 872,694 | +280.6% | 0.29% | +315.7% |
| APLS | New | APELLIS PHARMACEUTICALS INCcall | $4,166,144 | – | 126,400 | +100.0% | 0.29% | – |
| ARKK | Sell | ARK ETF TRinnovation etf | $3,868,550 | -65.2% | 35,000 | -58.8% | 0.27% | -63.7% |
| SRGA | Sell | SURGALIGN HOLDINGS INC | $3,824,304 | -22.1% | 3,508,536 | -9.6% | 0.26% | -19.0% |
| MRK | MERCK & CO INCcall | $3,657,857 | -3.4% | 48,700 | 0.0% | 0.25% | +0.8% | |
| DXCM | Sell | DEXCOM INC | $3,500,451 | -13.9% | 6,401 | -32.8% | 0.24% | -10.3% |
| SIBN | New | SI-BONE INC | $3,213,000 | – | 150,000 | +100.0% | 0.22% | – |
| ISRG | Buy | INTUITIVE SURGICAL INC | $3,126,602 | +31.6% | 3,145 | +21.8% | 0.22% | +37.3% |
| EVH | New | EVOLENT HEALTH INCcl a | $3,105,270 | – | 100,170 | +100.0% | 0.22% | – |
| KRTX | New | KARUNA THERAPEUTICS INC | $3,058,250 | – | 25,000 | +100.0% | 0.21% | – |
| A | Buy | AGILENT TECHNOLOGIES INC | $2,939,510 | +30.3% | 18,660 | +22.3% | 0.20% | +36.0% |
| PBYI | New | PUMA BIOTECHNOLOGY INC | $2,789,559 | – | 397,940 | +100.0% | 0.19% | – |
| VRDN | New | VIRIDIAN THERAPEUTICS INC | $2,632,000 | – | 160,000 | +100.0% | 0.18% | – |
| AUTL | Sell | AUTOLUS THERAPEUTICS PLCspon ads | $2,607,385 | -17.0% | 398,074 | -15.9% | 0.18% | -13.4% |
| LQDA | Sell | LIQUIDIA CORPORATION | $2,564,175 | -8.4% | 929,049 | -5.1% | 0.18% | -4.8% |
| MORF | New | MORPHIC HLDG INC | $2,469,504 | – | 43,600 | +100.0% | 0.17% | – |
| OM | Sell | OUTSET MED INC | $2,348,400 | -56.2% | 47,500 | -55.7% | 0.16% | -54.3% |
| ADAP | New | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $2,300,066 | – | 444,887 | +100.0% | 0.16% | – |
| HSTM | HEALTHSTREAM INC | $2,223,867 | +2.3% | 77,812 | 0.0% | 0.15% | +6.2% | |
| MREO | New | MEREO BIOPHARMA GROUP PLCads | $2,176,957 | – | 899,569 | +100.0% | 0.15% | – |
| ANAB | New | ANAPTYSBIO INC | $2,116,824 | – | 78,054 | +100.0% | 0.15% | – |
| NVAX | NOVAVAX INCcall | $2,073,100 | -2.4% | 10,000 | 0.0% | 0.14% | +1.4% | |
| EDIT | New | EDITAS MEDICINE INCput | $2,054,000 | – | 50,000 | +100.0% | 0.14% | – |
| AVRO | New | AVROBIO INC | $2,005,898 | – | 359,480 | +100.0% | 0.14% | – |
| GOSS | New | GOSSAMER BIO INC | $1,884,369 | – | 149,910 | +100.0% | 0.13% | – |
| MYO | New | MYOMO INC | $1,783,500 | – | 150,000 | +100.0% | 0.12% | – |
| ARGX | New | ARGENX SEsponsored adr | $1,735,292 | – | 5,746 | +100.0% | 0.12% | – |
| MRTX | New | MIRATI THERAPEUTICS INC | $1,654,993 | – | 9,355 | +100.0% | 0.12% | – |
| IQV | Buy | IQVIA HLDGS INC | $1,626,477 | +17.5% | 6,790 | +18.9% | 0.11% | +22.8% |
| LOGC | New | LOGICBIO THERAPEUTICS INC | $1,602,629 | – | 349,919 | +100.0% | 0.11% | – |
| ACIU | New | AC IMMUNE SA | $1,487,936 | – | 221,749 | +100.0% | 0.10% | – |
| MGTA | New | MAGENTA THERAPEUTICS INC | $1,447,839 | – | 198,879 | +100.0% | 0.10% | – |
| ORTX | New | ORCHARD THERAPEUTICS PLCads | $1,310,036 | – | 569,581 | +100.0% | 0.09% | – |
| AKYA | New | AKOYA BIOSCIENCES INC | $1,278,289 | – | 91,568 | +100.0% | 0.09% | – |
| RGEN | Buy | REPLIGEN CORP | $1,272,134 | +72.6% | 4,402 | +19.2% | 0.09% | +79.6% |
| ASMB | New | ASSEMBLY BIOSCIENCES INC | $1,218,000 | – | 350,000 | +100.0% | 0.08% | – |
| HSKA | Buy | HESKA CORP | $1,169,894 | +49.3% | 4,525 | +32.6% | 0.08% | +55.8% |
| AMN | Sell | AMN HEALTHCARE SVCS INC | $1,147,500 | -92.6% | 10,000 | -93.7% | 0.08% | -92.2% |
| CYCN | New | CYCLERION THERAPEUTICS INC | $1,141,902 | – | 371,955 | +100.0% | 0.08% | – |
| PHAS | New | PHASEBIO PHARMACEUTICALS INC | $933,000 | – | 300,000 | +100.0% | 0.06% | – |
| ENSG | Buy | ENSIGN GROUP INC | $779,177 | +0.1% | 10,397 | +15.9% | 0.05% | +3.8% |
| ELDN | New | ELEDON PHARMACEUTICALS INC | $704,569 | – | 114,008 | +100.0% | 0.05% | – |
| MIST | New | MILESTONE PHARMACEUTICALS IN | $648,639 | – | 113,597 | +100.0% | 0.04% | – |
| DCPH | New | DECIPHERA PHARMACEUTICALS INcall | $635,426 | – | 18,700 | +100.0% | 0.04% | – |
| FREQ | Sell | FREQUENCY THERAPEUTICS INCput | $479,374 | -48.0% | 67,900 | -26.6% | 0.03% | -45.9% |
| Sell | TELIGENT INC NEW | $426,717 | -68.1% | 1,069,465 | -57.2% | 0.03% | -66.3% | |
| CCRN | Sell | CROSS CTRY HEALTHCARE INC | $424,800 | -16.5% | 20,000 | -35.1% | 0.03% | -14.7% |
| FSTX | Sell | F-STAR THERAPEUTICS INC | $365,510 | -57.4% | 49,933 | -50.1% | 0.02% | -56.1% |
| FREQ | New | FREQUENCY THERAPEUTICS INC | $211,800 | – | 30,000 | +100.0% | 0.02% | – |
| BIIB | Exit | BIOGEN INCput | $0 | – | -2,000 | -100.0% | -0.05% | – |
| IMVT | Exit | IMMUNOVANT INC | $0 | – | -110,183 | -100.0% | -0.08% | – |
| GBT | Exit | GLOBAL BLOOD THERAPEUTICS INput | $0 | – | -40,000 | -100.0% | -0.09% | – |
| MCRB | Exit | SERES THERAPEUTICS INC | $0 | – | -59,560 | -100.0% | -0.10% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INCcall | $0 | – | -84,600 | -100.0% | -0.14% | – |
| AHAC | Exit | ALPHA HEALTHCARE ACQUISTN COcl a | $0 | – | -205,026 | -100.0% | -0.14% | – |
| OCUL | Exit | OCULAR THERAPEUTIX INC | $0 | – | -150,000 | -100.0% | -0.14% | – |
| TGTX | Exit | TG THERAPEUTICS INC | $0 | – | -69,760 | -100.0% | -0.18% | – |
| IPSC | Exit | CENTURY THERAPEUTICS INC | $0 | – | -100,901 | -100.0% | -0.20% | – |
| XENT | Exit | INTERSECT ENT INC | $0 | – | -175,389 | -100.0% | -0.20% | – |
| KDMN | Exit | KADMON HLDGS INC | $0 | – | -894,995 | -100.0% | -0.23% | – |
| CGEM | Exit | CULLINAN ONCOLOGY INC | $0 | – | -163,880 | -100.0% | -0.28% | – |
| AFMD | Exit | AFFIMED N V | $0 | – | -566,942 | -100.0% | -0.32% | – |
| OPCH | Exit | OPTION CARE HEALTH INC | $0 | – | -289,297 | -100.0% | -0.42% | – |
| TDOC | Exit | TELADOC HEALTH INCcall | $0 | – | -40,000 | -100.0% | -0.44% | – |
| TIP | Exit | ISHARES TRput | $0 | – | -70,000 | -100.0% | -0.60% | – |
| CI | Exit | CIGNA CORP NEW | $0 | – | -41,745 | -100.0% | -0.66% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -54,500 | -100.0% | -0.73% | – |
| XBI | Exit | SPDR SER TRput | $0 | – | -100,000 | -100.0% | -0.90% | – |
| OMCL | Exit | OMNICELL COM | $0 | – | -98,366 | -100.0% | -0.99% | – |
| ARKG | Exit | ARK ETF TRcall | $0 | – | -199,000 | -100.0% | -1.23% | – |
| OGN | Exit | ORGANON & CO | $0 | – | -699,696 | -100.0% | -1.41% | – |
| XBI | Exit | SPDR SER TRcall | $0 | – | -200,000 | -100.0% | -1.80% | – |
| BIIB | Exit | BIOGEN INCcall | $0 | – | -115,600 | -100.0% | -2.67% | – |
| QQQ | Exit | INVESCO QQQ TRput | $0 | – | -250,000 | -100.0% | -5.91% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2023-11-08
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMARIN CORP PLC | 21 | Q3 2023 | 12.5% |
| DANAHER CORPORATION | 21 | Q3 2023 | 8.1% |
| AFFIMED N V | 20 | Q3 2023 | 0.9% |
| ARGENX SE | 19 | Q3 2023 | 2.0% |
| GSK PLC | 18 | Q2 2022 | 13.1% |
| ASCENDIS PHARMA A/S | 18 | Q1 2022 | 7.7% |
| SANOFI | 18 | Q4 2022 | 7.2% |
| ENSIGN GROUP INC | 18 | Q1 2022 | 8.6% |
| CENTENE CORP DEL | 18 | Q3 2023 | 1.5% |
| ZOGENIX INC | 17 | Q4 2021 | 12.4% |
View Eversept Partners, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cabaletta Bio, Inc. | February 14, 2023 | 282,874 | 1.0% |
| Teligent, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| Teligent, Inc. | February 14, 2020 | 4,501,799 | 8.4% |
View Eversept Partners, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
View Eversept Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.